ArticleOncoimmunology2021

Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinoma.

Rosalinda Arends et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.